Impact of SSO-ASTRO Margin Guidelines on Re-excision Rate in Breast-conserving Surgery: A Single-center Experience.

Journal of cancer & allied specialties Pub Date : 2024-01-22 eCollection Date: 2024-01-01 DOI:10.37029/jcas.v10i1.559
Namra Urooj, Muhammad Abubakar, Kashif Asghar, Muhammad Hassan, Awais Amjad Malik, Bushra Rehman, Bakra Sajjad, Nifasat Farooqi, Zulqarnain Chaudhry, Asad Parvaiz, Amina Khan
{"title":"Impact of SSO-ASTRO Margin Guidelines on Re-excision Rate in Breast-conserving Surgery: A Single-center Experience.","authors":"Namra Urooj, Muhammad Abubakar, Kashif Asghar, Muhammad Hassan, Awais Amjad Malik, Bushra Rehman, Bakra Sajjad, Nifasat Farooqi, Zulqarnain Chaudhry, Asad Parvaiz, Amina Khan","doi":"10.37029/jcas.v10i1.559","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Breast-conserving surgery (BCS) has been historically linked with a high rate of re-excision. To address this issue, the Society of Surgical Oncology (SSO) and the American Society for Radiation Oncology (ASTRO) developed consensus guidelines in 2014 to standardize practices and improve clinical outcomes for BCS patients. In our tertiary cancer care hospital, we assessed the impact of these guidelines on the re-excision rate following BCS.</p><p><strong>Materials and methods: </strong>We conducted a retrospective study on breast cancer patients who underwent BCS at the Shaukat Khanum Memorial Cancer Hospital and Research Centre in Lahore, Pakistan. The study compared the re-excision rate before the implementation of the SSO-ASTRO consensus guidelines (November 2015-July 2017) and after the implementation (January 2018-August 2019). Margins were considered positive if \"ink on tumor\" was present and negative if \"no ink on tumor\" was present. Fisher's exact test or Chi-square test was used to compare the re-excision rates between the pre- and post-guideline periods.</p><p><strong>Results: </strong>A total of 919 patients were identified, with 533 from the pre-guideline period and 386 from the post-guideline period. Of the 919 patients, 31 with ductal carcinoma <i>in situ</i> (DCIS) were excluded from the re-excision analysis because the guidelines were not implemented on the DCIS. Furthermore, the overall rate of re-excision in our data was 4.3%. The re-excision rate decreased from 71.1% to 28.9% (<i>P</i> ≤ 0.05) following the adoption of the guidelines. We observed a statistically significant decrease in the re-excision rate after implementing the SSO-ASTRO guidelines.</p><p><strong>Conclusion: </strong>Implementation of the SSO-ASTRO margin guidelines led to a notable decrease in the overall re-excision rate in our data set. These findings suggest that continued adherence to the guidelines may lead to a further reduction in the re-excision rate in the future.</p>","PeriodicalId":73631,"journal":{"name":"Journal of cancer & allied specialties","volume":"10 1","pages":"559"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793721/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cancer & allied specialties","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37029/jcas.v10i1.559","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Breast-conserving surgery (BCS) has been historically linked with a high rate of re-excision. To address this issue, the Society of Surgical Oncology (SSO) and the American Society for Radiation Oncology (ASTRO) developed consensus guidelines in 2014 to standardize practices and improve clinical outcomes for BCS patients. In our tertiary cancer care hospital, we assessed the impact of these guidelines on the re-excision rate following BCS.

Materials and methods: We conducted a retrospective study on breast cancer patients who underwent BCS at the Shaukat Khanum Memorial Cancer Hospital and Research Centre in Lahore, Pakistan. The study compared the re-excision rate before the implementation of the SSO-ASTRO consensus guidelines (November 2015-July 2017) and after the implementation (January 2018-August 2019). Margins were considered positive if "ink on tumor" was present and negative if "no ink on tumor" was present. Fisher's exact test or Chi-square test was used to compare the re-excision rates between the pre- and post-guideline periods.

Results: A total of 919 patients were identified, with 533 from the pre-guideline period and 386 from the post-guideline period. Of the 919 patients, 31 with ductal carcinoma in situ (DCIS) were excluded from the re-excision analysis because the guidelines were not implemented on the DCIS. Furthermore, the overall rate of re-excision in our data was 4.3%. The re-excision rate decreased from 71.1% to 28.9% (P ≤ 0.05) following the adoption of the guidelines. We observed a statistically significant decrease in the re-excision rate after implementing the SSO-ASTRO guidelines.

Conclusion: Implementation of the SSO-ASTRO margin guidelines led to a notable decrease in the overall re-excision rate in our data set. These findings suggest that continued adherence to the guidelines may lead to a further reduction in the re-excision rate in the future.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
SSO-ASTRO边缘指南对保乳房手术中再次切除率的影响:单中心经验
简介保乳手术(BCS)历来与高重切率有关。为解决这一问题,肿瘤外科学会(SSO)和美国放射肿瘤学会(ASTRO)于 2014 年制定了共识指南,以规范操作并改善 BCS 患者的临床疗效。在我们的三级癌症治疗医院,我们评估了这些指南对 BCS 后再次切除率的影响:我们对在巴基斯坦拉合尔肖卡特-卡努姆纪念癌症医院和研究中心接受 BCS 的乳腺癌患者进行了一项回顾性研究。研究比较了SSO-ASTRO共识指南实施前(2015年11月-2017年7月)和实施后(2018年1月-2019年8月)的再切除率。如果 "肿瘤上有墨迹",则边缘被视为阳性;如果 "肿瘤上没有墨迹",则边缘被视为阴性。采用费雪精确检验或卡方检验比较指南实施前后的再切除率:结果:共发现 919 例患者,其中 533 例来自指南发布前,386 例来自指南发布后。在这 919 名患者中,有 31 名患有导管原位癌(DCIS)的患者被排除在再次切除分析之外,因为指南并未针对 DCIS 实施。此外,在我们的数据中,再次切除的总体比例为 4.3%。采用该指南后,再次切除率从 71.1% 降至 28.9%(P ≤ 0.05)。我们观察到,在实施 SSO-ASTRO 指南后,再次切除率在统计学上有了明显下降:结论:在我们的数据集中,SSO-ASTRO 边界指南的实施显著降低了总体再切除率。这些研究结果表明,今后继续遵循该指南可能会进一步降低再切除率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
12 weeks
期刊最新文献
Marginal Contribution of Pathogenic RAD51D Germline Variants to Pakistani Early-Onset and Familial Breast/Ovarian Cancer Patients. Mitigating Cardiotoxicity Associated with Anticancer Drugs: An Updated Systematic Review. Survival Outcomes in Malignancy-related Hypercalcemia: A Tertiary Care Single-center Experience. Cancer Statistics from the Shaukat Khanum Memorial Trust's Hospital-based Cancer Registry, Pakistan, 1994-2022: An Observational Study. Clinical Outcome of Patients Receiving Rituximab in Combination with Bendamustine in Indolent B-cell Lymphomas: A Single-center Institutional Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1